Showing results (221-230 of 7,001) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalenceDonita R Croft, John Trapp, Kemp Kernstine, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factorsTsuyoshi Kodani, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysisT Berghmans, M Paesmans, J J Lafitte, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2003
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use programA G Pallis, D Mavroudis, N Androulakis, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2003
In vitro effects of combinations of cis-amminedichloro (2-methylpyridine) platinum (II) (ZD0473) with other novel anticancer drugs on the growth of SBC-3, a human small cell lung cancer cell lineF Kanzawa, Y Akiyama, N Saijo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancerJ I Clark, K Kancharla, R Qamar, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631M P Kosty, J E Herndon, N J Vogelzang, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2001
Serum endostatin correlates with progression and prognosis of non-small cell lung cancerMakoto Suzuki, Toshihiko Iizasa, Eitetu Ko, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2001
Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancerD Dworakowska, S Gózdz, E Jassem, et al.
Lung Cancer (Amsterdam, Netherlands)|December 26, 2001
A phase II study of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer: clinical outcomes and quality of lifeJacek Jassem, Maciej Krzakowski, Kazimierz Roszkowski, et al.
Pageof 701